Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph not_applicable
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Other(3)

Detailed Status

unknown3
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

unknown375%
enrolling_by_invitation125%

Recent Activity

0 active trials
Showing 4 of 4
unknown

Expanded Access Protocol Using HBOC-201

NCT02684474
enrolling_by_invitationnot_applicable

Expanded Access Study of HBOC-201 (Hemopure) for the Treatment of Life-Threatening Anemia

NCT01881503
unknown

Expanded Access IND Administration of HBOC-201 in Patients With Severe Acute Anemia

NCT03633604
unknown

HBOC-201 Expanded Access Protocol for Life-threatening Anemia for Whom Allogeneic Blood Transfusion is Not an Option

NCT02934282

Clinical Trials (4)

Showing 4 of 4 trials
NCT02684474

Expanded Access Protocol Using HBOC-201

Unknown
NCT01881503Not Applicable

Expanded Access Study of HBOC-201 (Hemopure) for the Treatment of Life-Threatening Anemia

Enrolling By Invitation
NCT03633604

Expanded Access IND Administration of HBOC-201 in Patients With Severe Acute Anemia

Unknown
NCT02934282

HBOC-201 Expanded Access Protocol for Life-threatening Anemia for Whom Allogeneic Blood Transfusion is Not an Option

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4